Jorge Posada confirms he won’t be back with Yankees

18 Comments

This will come as no surprise to anyone with a basic knowledge of the Yankees’ roster. But, alas…

According to the AP, via NBCSports.com, free agent Jorge Posada said Wednesday before an annual dinner for his charitable foundation that he will not be back with the Yankees for the 2012 season.

Posada also told reporters that he hasn’t completely ruled out retirement, though he has already drawn free agent interest from “five to six” MLB teams.

“I feel I’m undecided,” said Posada. “I don’t know if I want to play. I don’t know if I want to stay home. I’m having fun with the kids and with the family, but I don’t know what I want to do. I don’t want to make the mistake of telling you that I’m not going to play or telling you that I’m going to play when I don’t know what I want to do. … I will always be a Yankee.”

Posada batted just .235/.315/.398 in 387 plate appearances this season. He is no longer a capable catcher and probably shouldn’t be signed as anything more than a part-time designated hitter. But the 40-year-old could probably find an incentives-based major league contract if he truly wants to continue his career.

The Yanks will turn DH duties over to a combination of Jesus Montero, Alex Rodriguez and Derek Jeter.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.